Down-regulation of hK7 in the sera of breast cancer and benign breast disease patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Down-regulation of hK7 in the sera of breast cancer and benign breast disease patients

Published:2017-07 Issue:7 Volume:3 Page:e00356
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Ejaz Samina,Nasim Faiz-ul-Hassan,Ashraf Muhammad,Ahmad Gulzar

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference34 articles.

1. Global cancer rates could increase by 50% to 15 millionby 2020;WHO,2003

2. Prognostic factors affecting disease-free survival rate following surgical resection of primary breast cancer;Horita;Eur. J. Histochem.,2001

3. Her-2/neu and breast cancer;Kaptain;Diagn. Mol. Pathol.,2001

4. Cancer Facts & Figure,2017

5. Breast cancer claims 40,000 lives a year in Pakistan;Junaidi,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Kallikrein 7 in Tumorigenesis;Current Medicinal Chemistry;2021-09-15

2. Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer;Journal of Ovarian Research;2020-10-21

3. Analysis of expression and prognosis of KLK7 in ovarian cancer;Open Medicine;2020-09-30

4. Overview of tissue kallikrein and kallikrein-related peptidases in breast cancer;Biological Chemistry;2018-09-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP